A new step forward is in the works for the new research program implemented at the beginning of the year at the Douglas Mental Health Institute that is aimed at the early detection of Alzheimer’s disease.
The next stage of this five-year study will consist in validating new diagnostic criteria that could translate into the possibility of establishing early detection, which will help doctors explore efficient treatment or changes in lifestyle that could stop the progression of Alzheimer’s disease.

Comparing results and publishing a progress report

Serge Gauthier, MD, FRCPC, researcher at the Douglas Mental Health University Institute and director of the Alzheimer’s Disease Research Unit at the McGill Centre for Studies in Aging, will be in Chicago from July 26 to 31 to participate in the International Conference on Alzheimer’s Disease (ICAD). He will present his results from neuroimaging techniques, such as positron emission tomography (PET) and magnetic resonance imaging (MRI), which were used to detect the disease early on. Serge Gauthier, along with Douglas researcher Pedro Rosa-Neto, MD, PhD, will analyse these results by comparing them with the data of other scientists from research centres in Europe and North America who participate, like the Douglas, in a common research consortium on the same topic.

Serge Gauthier and his team published a progress report in the August issue of The Lancet Neurology.

Media resources

Serge Gauthier will be available for interviews.
From July 21 to 25: by phone and in person (in Montreal).
From July 28 to August 1: by phone only (from Chicago).